Capabilities · Materials, logistics & supply support

Cold-chain & distribution planning

A proposed service scope for temperature-controlled transit, connecting route evaluation, packaging configuration, thermal monitoring and journey risk assessment.

PlannedCatalogue scope

Illustrative unbranded insulated shipper and logger detail.
Illustrative unbranded insulated shipper and logger detail. It does not depict Luang Pharma's project, products or installed equipment.

Service statusPlanned

Planned.

Technical boundaries and readiness need confirmation before an activity could be presented as available.

Basis · Catalogue scope

Status
PlannedNo available service asserted
Source-plan relationship
Catalogue scopeProposed catalogue expansion
Readiness
Not establishedProduct and process evidence needed
Facility roadmap
First commercial batch target Q1 2028 · indicativeNot a service date

01 · Proposed service scope

Start with the product and its container.

Cold-chain and distribution planning are presented as a planned service domain. The product sensitivity, proposed transit lanes and seasonal variations would define its necessary scope.

The proposed services catalogue adds distribution planning as an extension for technical discussion. It lies outside the initial project plan and would need complete scope confirmation.

Active refrigerated transport and passive insulated packaging are distinct technical subjects. Inclusion in a common catalogue does not establish that one strategy suits a particular route.

Catalogue boundary

A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.

02 · Presentation families

Match the route to the format.

Planned formats and their source relationship
FormatPlanning noteBasisStatus
Passive insulated packagingQualified shippers and phase-change materials for defined thermal protection durations.Catalogue scopePlanned
Active temperature-controlled transitMechanically refrigerated transport options for continuous environmental control during movement.Catalogue scopePlanned
Biological sample transportBiological drug-substance developmentSpecialised handling profiles for diagnostic specimens or sensitive biological intermediates.Catalogue scopePlanned
Clinical material distributionClinical & investigational supply developmentControlled routing and traceability considerations for investigational medicinal product shipments.Catalogue scopePlanned

03 · Process scope for discussion

Make the sequence and its evidence visible.

01 · Process stage

Planned

Transit lane assessment

Evaluate proposed shipping routes, transfer points, expected transit durations and potential environmental extremes.

02 · Process stage

Planned

Packaging configuration selection

Consider insulated container systems, cooling media and specific payload dimensions for the journey.

03 · Process stage

Planned

Thermal monitoring strategy

Define the placement of temperature monitors and required recording intervals during the transit period.

04 · Process stage

Planned

Risk mitigation planning

Identify potential transit delays, customs inspection holds and appropriate contingency actions for the shipment.

05 · Process stage

Planned

Transport execution controls

Outline the procedural steps for configuring shippers, labelling and transferring materials to the carrier.

06 · Process stage

Planned

Journey data review

Examine the downloaded temperature records and assess conditions against the defined transit thermal boundaries.

Illustrative sequence

This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.

04 · Supporting services

No service stands alone.

01PlannedCatalogue scope

Qualified storage & warehousing

Storage conditions, status segregation and supporting system evidence.

Explore proposed scope

02PlannedCatalogue scope

Clinical & investigational supply development

Study-specific manufacturing, packaging and documentation requirements; permissions remain separate.

Explore proposed scope

03PlannedCatalogue scope

Returns, recalls & disposal coordination

Future lifecycle responsibilities and appropriate controls.

Explore proposed scope

05 · Readiness questions

A service claim needs a defined evidence base.

Product stability profile
Exact thermal degradation limits, acceptable excursion boundaries and physical shock sensitivity.
Transit systems
Relevant qualified packaging designs, calibrated loggers and an approved lane strategy.
Monitoring evidence
Downloaded transit records, calibration certificates and documentation of any physical damage.
Quality responsibilities
Accountable personnel for reviewing transit data and reaching a final disposition decision.
Regulatory context
Applicable distribution practices for pharmaceutical shipments crossing the intended jurisdictional borders.
Technical agreement
Responsibilities, disclosure terms and transit boundaries for any future distribution engagement.

06 · Practical questions

Before a technical discussion.

Is this service currently available?

No. The service is Planned. This page is a scope proposal and does not establish an operating cold-chain or distribution service.

Does the scope include active and passive systems?

No. The wider catalogue identifies active transport and passive packaging as separate possibilities. Every distinct transit mechanism requires separate scope confirmation.

What information helps define the question?

Identify the proposed product, thermal limits, intended transit lane and the technical question. Confidential data should only be shared through an agreed route.

Is there a service launch quarter?

No. No service-specific quarter is established. The project-wide indicative milestones do not commit any individual service to a start date.

Does a technical discussion establish supply?

No. Feasibility, scope, permissions, evidence and any agreement would need to be established before a transit commitment.

Back to capabilities

Professional enquiries

Discuss a defined question.

Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.

Contact Luang Pharma